Lataa...
Myeloperoxidase to Risk Stratify Emergency Department Patients with Chest Pain
Previous studies suggest that serum myeloperoxidase (MPO) is a potentially useful biomarker to risk stratify troponin-negative patients with suspected myocardial ischemia. We hypothesized that the relationship between initial serum MPO levels would correlate with 30-day adverse cardiac outcomes for...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Master Publishing Group
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3614767/ https://ncbi.nlm.nih.gov/pubmed/23675127 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|